The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Patents, Royalties, Other Intellectual Property - Duke Unversity (Inst)
A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503.
 
Federico Innocenti
Consulting or Advisory Role - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Royalties from the Mayo Foundation on the UGT1A1 testing
 
Kouros Owzar
No Relationships to Disclose
 
Chen Jiang
Patents, Royalties, Other Intellectual Property - Duke Cancer Institute (Inst)
 
Alexander Sibley
Patents, Royalties, Other Intellectual Property - Duke Cancer Institute (Inst)
 
Flora Mulkey
Patents, Royalties, Other Intellectual Property - Duke Cancer Institute (Inst)
 
Lisa A. Carey
Research Funding - Genentech/Roche; GlaxoSmithKline
 
Debu Tripathy
Consulting or Advisory Role - Merck; Nektar; Novartis; Oncoplex Diagnostics; Pfizer
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Bryan P. Schneider
No Relationships to Disclose
 
William Thomas Barry
No Relationships to Disclose
 
Eric P. Winer
Honoraria - Verastem
Consulting or Advisory Role - Genentech/Roche; Novartis; Verastem
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Clifford A. Hudis
Other Relationship - Breast Cancer Research Foundation
 
Howard L. McLeod
Stock and Other Ownership Interests - Cancer Genetics
Consulting or Advisory Role - Cancer Genetics; Gentris; NIH/NCI; Saladax Biomedical
 
Maura N. Dickler
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech/Roche; Merrimack; Novartis; Pfizer; Syndax
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst)